Comparing Heterologous and Homologous COVID-19 Vaccination: A Longitudinal Study of Antibody Decay

Comparing Heterologous and Homologous COVID-19 Vaccination: A Longitudinal Study of Antibody Decay

The humoral response after vaccination was evaluated in 1248 individuals who received different COVID-19 vaccine schedules. The study compared subjects primed with adenoviral ChAdOx1-S (ChAd) and boosted with BNT162b2 (BNT) mRNA vaccines (ChAd/BNT) to homologous dosing with BNT/BNT or ChAd/ChAd vacc...

Full description

Bibliographic Details
Main Authors: Chiara Orlandi, Giuseppe Stefanetti, Simone Barocci, Gloria Buffi, Aurora Diotallevi, Ettore Rocchi, Marcello Ceccarelli, Sara Peluso, Daniela Vandini, Eugenio Carlotti, Mauro Magnani, Luca Galluzzi, Anna Casabianca
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Viruses
Subjects:
SARS-CoV-2
COVID-19
heterologous vaccination
anti-Spike IgG response
antibody decay
Online Access:https://www.mdpi.com/1999-4915/15/5/1162

Similar Items

Similar Items